ScreenerHero

WBIOWPD Pharmaceuticals Inc.

CNQ · CA · Healthcare · Biotechnology · wpdpharmaceuticals.com
0.0700CAD0.00%Mkt Cap: 236513 $P/E: —

WPD Pharmaceuticals Inc. does not have any significant operations. Previously, it was engaged in the research and development of medicinal products in the fields of oncology. The company is headquartered in Vancouver, Ca…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.84BUSDP/E 29.6
REGN
Regeneron Pharmaceuticals, Inc.
$80.80BUSDP/E 19.4
MRNA
Moderna, Inc.
$69.04BUSD
ARGX
argenx SE
$58.67BUSDP/E 37.9
ARGX
argenx SE
$61.45BUSDP/E 37.7
UCB
UCB SA
$43.96BUSDP/E 18.7
RVMD
Revolution Medicines, Inc.
$40.93BUSD
ONC
BeOne Medicines AG
$39.69BUSDP/E 62.9
RPRX
Royalty Pharma Plc Class A
$33.75BUSDP/E 31.4
ALNY
Alnylam Pharmaceuticals, Inc.
$32.69BUSDP/E 42.5
ROIV
Roivant Sciences Ltd. Common Shares
$28.73BUSD
INSM
Insmed Incorporated
$26.42BUSD
INCY
Incyte Corporation
$25.27BUSDP/E 15.9
BNTX
BioNTech SE
$24.62BUSD
GMAB
Genmab A/S
$20.24BUSDP/E 27.4
GMAB
Genmab A/S
$21.33BUSDP/E 27.5
JAZZ
Jazz Pharmaceuticals plc
$15.67BUSDP/E 16.5
ASND
Ascendis Pharma A/S
$15.63BUSDP/E 18.5
SMMT
Summit Therapeutics Inc.
$14.24BUSD
EXEL
Exelixis, Inc.
$14.18BUSDP/E 18.0

Key Statistics

Company
Market Cap236.51K $
Enterprise Value514.37K $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-58.32K $
Revenue/Share—
Last Price0.0700 CAD
Fiscal Year EndDec 2023
MR QuarterSep 2024
Employees—
CountryCA
SectorHealthcare
IndustryBiotechnology
ISINCA92941F1053
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-2.48
EV/Revenue—
P/S—
P/B-0.52
EPS (TTM)-0.02
EPS (Forward)—
52W Range
—
52W High0.0700 CAD
52W Low0.0700 CAD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE14.40%
ROA-23.12%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-149.36K $
CapEx (TTM)—
FCF Margin—
FCF Yield-80.70%
Net Debt277.86K $
Net Debt/EBITDA-1.34
Balance Sheet
Debt/Equity-0.55
Current Ratio0.10
Quick Ratio0.10
Book Value/Sh-0.1340 CAD
Cash/Share0.0020 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 CAD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:25
Split DateDec 30, 2024
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.4.64M
Float3.17M
Insiders0.00%
Institutions0.00%
Short Interest
Short Ratio0.9d
Short % Out.0.00%
Shares Short233
Short (prev mo.)4.95K
Technical
SMA 500.0700 (+0.0%)
SMA 2000.0700 (+0.0%)
Beta0.17
S&P 52W Chg14.29%
Avg Vol (30d)0
Avg Vol (10d)0
Technical Indicators
RSI (14)100.0
MACD0.0000
MACD Signal0.0000
MACD Hist.+0.0000
BB Upper0.0700 CAD
BB Middle0.0700 CAD
BB Lower0.0700 CAD
BB Width0.00%
ATR (14)0.0000 CAD
Vol Ratio (20d)—